Nuwellis (NUWE) Revenue Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 26.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.21% |
| Dec 31, 2025 | 4.39% |
| Sep 30, 2025 | -6.34% |
| Jun 30, 2025 | -21.38% |
| Mar 31, 2025 | 2.53% |
| Dec 31, 2024 | -8.98% |
| Sep 30, 2024 | -1.87% |
| Jun 30, 2024 | 5.73% |
| Mar 31, 2024 | 1.70% |
| Dec 31, 2023 | 9.06% |
| Sep 30, 2023 | 16.80% |
| Jun 30, 2023 | -6.24% |
| Mar 31, 2023 | -5.19% |
| Dec 31, 2022 | 42.45% |
| Sep 30, 2022 | 11.44% |
| Jun 30, 2022 | -11.76% |
| Mar 31, 2022 | 0.42% |
| Dec 31, 2021 | -19.67% |
| Sep 30, 2021 | -2.68% |
| Jun 30, 2021 | 34.62% |
| Mar 31, 2021 | 17.67% |
| Dec 31, 2020 | 49.52% |
| Sep 30, 2020 | 52.08% |
| Jun 30, 2020 | 11.09% |
| Mar 31, 2020 | 34.16% |
| Dec 31, 2019 | -8.81% |
| Sep 30, 2019 | -8.14% |
| Jun 30, 2019 | 52.59% |
| Mar 31, 2019 | 17.16% |
| Dec 31, 2018 | 80.39% |
| Sep 30, 2018 | 42.42% |
| Jun 30, 2018 | 27.20% |
| Mar 31, 2018 | 15.09% |
| Dec 31, 2017 | 11.39% |
| Sep 30, 2017 | 76.24% |
| Mar 31, 2015 | 0.00% |
| Sep 30, 2014 | 0.00% |